0 yen inflation surcharge for initial/follow-up consultations, 130-840 yen per day for hospitalizations... Medical Fee Revision (Yomiuri Shimbun Online) – Yahoo! News

News Highlights

With the medical fee revision for fiscal year 2026, a new "Price Increase Response Fee" of 20 yen will be established for initial and follow-up visits to address the rising cost of living. For inpatients, an increase of 130 to 840 yen per day is expected. This revision aims to improve the financial performance of medical institutions and respond to the management pressure caused by price inflation.

M&A Medical Editorial Department's Perspective

今回の診療報酬改定における「物価高騰対応加算」の新設は、医療機関、特に中小規模のクリニックや病院にとって、経営の安定化に直結する重要な変更点です。初診・再診時の20円増は小規模ながらも確実な収益増につながり、入院患者への1日130円～840円の引き上げは、人件費や光熱費、医薬品費の高騰に苦しむ医療現場にとって、一定の緩和策となるでしょう。しかし、この加算だけでは物価高の全てをカバーできない可能性も高く、特に設備投資や人材確保に多額の資金を要する医療機関では、M&Aによる規模のメリット追求や、特定医療法人・社会医療法人への移行による税務スキームの活用といった、より抜本的な経営戦略・承継戦略が不可欠になります。改定サイクルを見据え、中長期的な視点での事業承継計画と財務戦略を練ることが、今後の持続的な経営の鍵となります。

Points Raised by This News

• The 20 yen increase for initial and follow-up visits may contribute to revenue improvement for small clinics.
• The increase of 130-840 yen per day for inpatients serves as a partial measure to alleviate the rising costs of labor and materials.
• The importance of mid-to-long-term management and succession strategies, aligned with the medical fee revision cycle, is increasing.
• Facility standardization and the dispersion of investment burdens through group formation become more realistic options.

Practical Questions Arising from This News

• To what extent will revenue actually improve with this new fee?
• What other management efforts can be considered as a response to rising prices, besides the new fee?
• How will trends in medical fee revisions affect the timing of M&A?

If You Feel "Should I Consult Too?"

For medical institution managers who feel that the slight revenue increase from this revision will not fully resolve the burden of rising prices, we recommend reviewing your clinic's or hospital's financial status and future plans with an expert. Especially if you have concerns aboutLack of Successoror future investments in facilities and personnel, it is a good opportunity to consider consultations to broaden your options, including business succession through M&A or corporate conversion utilizing tax incentives.

M&A Medical (CentralMedience Inc.) is a business succession support service for medical corporations, hospitals, and clinics, certified by the Small and Medium Enterprise Agency as an M&A support institution. We provide comprehensive support.Success FeeWe handle consultations with strict confidentiality.Contact Us for a Free Consultation